SNTI

SNTI

USD

Senti Biosciences Inc. Common Stock

$1.810-0.110 (-5.729%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.920

Máximo

$2.020

Mínimo

$1.800

Volumen

0.05M

Fundamentos de la Empresa

Capitalización de Mercado

47.3M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.19M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.26Actual $1.810Máximo $16.94

Noticias Relacionadas

GlobeNewswire

Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating relapsed/refractory Acute Myeloid

Ver más
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Senti Biosciences with a Buy rating and announces Price Target of $12.

Ver más
HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.